A detailed history of Cumberland Partners LTD transactions in Pfizer Inc stock. As of the latest transaction made, Cumberland Partners LTD holds 76,600 shares of PFE stock, worth $2.03 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
76,600
Holding current value
$2.03 Million
% of portfolio
0.15%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$24.8 - $30.19 $1.9 Million - $2.31 Million
76,600 New
76,600 $2.03 Million
Q2 2022

Aug 10, 2022

BUY
$46.53 - $55.17 $41,877 - $49,653
900 Added 6.12%
15,610 $818,000
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $217,678 - $269,731
4,758 Added 47.81%
14,710 $761,000
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $411,216 - $609,560
9,952 New
9,952 $588,000
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $206,820 - $250,860
-6,000 Closed
0 $0
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $197,879 - $210,959
6,000 New
6,000 $218,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cumberland Partners LTD Portfolio

Follow Cumberland Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Cumberland Partners LTD with notifications on news.